Clinical Trials Logo
NCT number NCT03172598
Study type Interventional
Source Mitsubishi Tanabe Pharma Corporation
Contact Clinical Trials Information Desk, to prevent miscommunication,
Phone please email:
Email info@mt-pharma-eu.com
Status Not yet recruiting
Phase Phase 2
Start date July 2017
Completion date August 2018

Clinical Trial Summary

A Study to Investigate the Safety, Tolerability and Efficacy of Multiple Doses of MT-8554 in Subjects with Painful Diabetic Peripheral Neuropathy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Completed NCT01726413 - A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). Phase 2
 Terminated NCT01280747 - Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study Phase 4
 Completed NCT01455415 - Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain Phase 3